Mabion S.A. (WSE:MAB)
Poland flag Poland · Delayed Price · Currency is PLN
8.26
+0.01 (0.12%)
Jan 28, 2026, 5:00 PM CET

Mabion Revenue

Mabion had revenue of 4.08M PLN in the quarter ending September 30, 2025, with 691.47% growth. This brings the company's revenue in the last twelve months to 14.81M, down -86.63% year-over-year. In the year 2024, Mabion had annual revenue of 69.02M, down -54.50%.

Revenue (ttm)
14.81M
Revenue Growth
-86.63%
P/S Ratio
9.00
Revenue / Employee
70.53K
Employees
213
Market Cap
133.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202469.02M-82.66M-54.50%
Dec 31, 2023151.68M-12.30M-7.50%
Dec 31, 2022163.98M127.92M354.72%
Dec 31, 202136.06M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BIOTON295.81M
Ryvu Therapeutics90.41M
Synthaverse71.76M
Captor Therapeutics Spolka Akcyjna7.57M
Molecure5.86M
Urteste1.80M
Pharmena1.27M
Poltreg250.00K
Revenue Rankings